Core Insights - The "Pain to Performance" podcast has achieved a ranking of 78 in the Business category on Apple Podcasts, indicating rapid growth since its launch in late 2024 [1][3]. Podcast Overview - The podcast features weekly in-depth conversations with clinicians, performance specialists, and business professionals, focusing on the relationship between pain and performance [3]. - Topics discussed include nervous system science, trauma recovery, workplace burnout, and AI-driven productivity, all framed around understanding pain [3][4]. Unique Approach - The host, Bradlee Morgan, emphasizes making expert knowledge accessible by asking insightful questions and translating complex concepts into relatable language [4][9]. - The podcast aims to empower listeners by cutting through jargon and focusing on practical takeaways from expert discussions [4]. Audience and Relevance - The podcast intentionally bridges health literacy and professional performance, appealing to leaders and entrepreneurs who recognize the impact of physical and mental stress on decision-making and productivity [4]. - Recent episodes have addressed themes such as AI strategies, trauma's influence on workplace behavior, and the nervous system's role in leadership [4]. Notable Episodes - Featured episodes include discussions on AI's role in business, trauma's effects on the body, and the distinction between symptom relief and systemic change [5][6][7]. Availability - "Pain to Performance" is available on Apple Podcasts and other major podcast platforms, with new episodes released weekly [8].

want to welcome Dick Thompson to the broadcast. He's the CEO of The Atlantic magazine as a former editor chief of Wired magazine. I want to talk to you about media and AI and all sorts of things, but I want to talk to you about this book uh because I am not a runner. I have always wanted to be a runner and I read your book and it's actually quite inspiring because it's not really I want to say it's not really about running.>> That is correct. >> It's I mean there is a running element to it but you run almos ...

As filed with the Securities and Exchange Commission on February 6, 2024 Registration No. 333-269188 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 11 to FORM S-1 REGISTRATION STATEMENT under The Securities Act of 1933 CHROMOCELL THERAPEUTICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 86-3335449 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer I ...